Crestwood Advisors Group LLC Decreases Stake in Xylem Inc. $XYL

Crestwood Advisors Group LLC cut its position in Xylem Inc. (NYSE:XYL) by 2.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 451,014 shares of the industrial products company’s stock after selling 12,624 shares during the period. Xylem accounts for 1.1% of Crestwood Advisors Group LLC’s investment portfolio, making the stock its 22nd largest holding. Crestwood Advisors Group LLC owned approximately 0.19% of Xylem worth $66,523,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. Impax Asset Management Group plc boosted its stake in shares of Xylem by 13.7% in the second quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock valued at $709,183,000 after buying an additional 663,191 shares in the last quarter. Ferguson Wellman Capital Management Inc. acquired a new stake in Xylem in the third quarter valued at $1,148,000. Vanguard Personalized Indexing Management LLC boosted its position in shares of Xylem by 19.0% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 56,216 shares of the industrial products company’s stock worth $8,292,000 after purchasing an additional 8,960 shares in the last quarter. XXEC Inc. grew its stake in shares of Xylem by 66.0% during the 2nd quarter. XXEC Inc. now owns 33,698 shares of the industrial products company’s stock worth $4,359,000 after purchasing an additional 13,404 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc increased its holdings in shares of Xylem by 9.8% in the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 417,651 shares of the industrial products company’s stock valued at $61,629,000 after purchasing an additional 37,189 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Performance

NYSE XYL opened at $128.14 on Tuesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $154.27. The firm has a market capitalization of $31.20 billion, a P/E ratio of 32.69, a P/E/G ratio of 1.83 and a beta of 1.17. The business’s 50-day simple moving average is $138.28 and its 200-day simple moving average is $142.01.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 EPS for the quarter, meeting the consensus estimate of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.37 billion. During the same quarter last year, the firm posted $1.18 earnings per share. Xylem’s revenue for the quarter was up 6.3% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Equities analysts predict that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Tuesday, February 24th will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.3%. This is an increase from Xylem’s previous quarterly dividend of $0.40. The ex-dividend date is Tuesday, February 24th. Xylem’s payout ratio is 40.82%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Royal Bank Of Canada lowered their target price on shares of Xylem from $176.00 to $162.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 11th. The Goldman Sachs Group set a $158.00 price target on Xylem in a report on Wednesday, February 11th. Barclays decreased their target price on Xylem from $166.00 to $156.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 11th. Oppenheimer set a $165.00 price target on Xylem in a research report on Thursday. Finally, Citigroup decreased their price objective on shares of Xylem from $182.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Nine investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $158.08.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.